Glutethimide

This classification denotes a sedative and hypnotic with the molecular formula C13H15NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C8I4BVN78E, chemically known as 2,6-piperidinedione, 3-(4-aminophenyl)-3-ethyl- but generally known as glutethimide, which bears US NIH Compound Identifier 2145. European Medicines Agency schedules Glutethimide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07945MIG. The term GLUTETHIMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). World Health Organization schedules glutethimide in its Anatomical Therapeutic Chemical (ATC) Classification. GLUTETHIMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule glutethimide under HS 29251200 and SITC 51482. As of Q4 2014, GLUTETHIMIDE remains the US FDA Preferred Term for this commodity. Glutethimide bears US NLM identifiers UMLS ID C0017845 and NCI Concept Code C65807. SMILES: O=C1NC(=O)CCC1(CC)C1CCC(N)CC1.